MedTrace Logo

A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms

NCT01286194 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2011-01-31

No results posted yet for this study

Summary

This is a multi-center, open-label, all-comers OTC actual use study in pharmacy sites where the principal investigator will be a pharmacist.

Conditions

  • Frequent Heartburn

Interventions

DRUG

Rabeprazole sodium

Rabeprazole sodium 10 mg orally every day for 14 days

Sponsors & Collaborators

  • Eisai Inc.

    lead INDUSTRY

Principal Investigators

  • Marco Cyrille, MD · Eisai Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2007-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01286194 on ClinicalTrials.gov